Inventor
KONDA VEERA
US13 patents
⚠️ This page may combine multiple inventors who share the name “KONDA VEERA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRIPP MATTHEW L
5 patentsUS8475850B2Jul 2, 2013
Methods and compositions for heavy metal detoxification
TRIPP MATTHEW L6 citations82
US8206753B2Jun 26, 2012
Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
TRIPP MATTHEW L6 citations82
US8263139B2Sep 11, 2012
Protein kinase modulation by hops and Acacia products
TRIPP MATTHEW L3 citations61
US8815306B2Aug 26, 2014
Methods and compositions for promoting bone and joint health
TRIPP MATTHEW L1 citations50
US8241674B2Aug 14, 2012
Methods and compositions for heavy metal detoxification
TRIPP MATTHEW L0 citations49
KINDEX PHARMACEUTICALS INC
3 patentsUS10343977B2Jul 9, 2019
Tetrahydro-isohumulone derivatives, methods of making and using
KINDEX PHARMACEUTICALS INC0 citations46
US9828331B2Nov 28, 2017
Tetrahydro-isohumulone derivatives, methods of making and using
KINDEX PHARMACEUTICALS INC0 citations46
US8829056B2Sep 9, 2014
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
KINDEX PHARMACEUTICALS INC0 citations46
METAPROTEOMICS LLC
2 patentsCARROLL BRIAN J
2 patentsUS8410178B2Apr 2, 2013
CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
CARROLL BRIAN J3 citations55
US8410179B2Apr 2, 2013
Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
CARROLL BRIAN J0 citations45